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ABSTRACT
This thesis examines the preparation of phenyl-, benzyl-, bisbenzyl- and
phenylethylisoquinolines possessing a biaryl moiety, based on the structures of
reticuline and laudanosine. The synthetic strategy involves the formation of an
appropriately protected biphenyl unit followed by construction of the isoquinoline unit
by converting the biphenyl into a 2-[3,4-dimethoxyphenyl]ethylamide, cyclising the
amide under Bischler-Napieralski cyclisation conditions and reducing the resulting
imine under conditions that will also reductively methylate the isoquinoline nitrogen.
In Chapter 2, the bisbenzylisoquinoline 49 was the primary synthetic target. Formation
of the biphenyl moiety was investigated using the Ullmann coupling reaction of halides
89 or the oxidative coupling of ester 97 to form the symmetrical biphenyl 94. The
Ullmann reaction proved to be the best method for preparing dimer 94, isolated in 69 %
yield. Oxidative formation of 94 was achieved with a best yield of 55 % with MoCl5 as
the oxidant, however a chlorinated side product was also observed. Following formation
of 94, the isoquinoline rings of 49 were built up by formation of the bisamide 100,
which cyclised under Bischler-Napieralski to an unstable bisimine. Reduction afforded
diastereomeric amines 102, separable by silica gel column chromatography, and
reductive methylation of the major diastereomer afforded the bisbenzylisoquinoline 49.
Compounds 102 and 49 were subjected to biological assay and found to be poorly
biologically active. Our synthetic effort then turned to the preparation of phenyl-,
benzyl, and phenylethylisoquinolines each possessing a biaryl moiety. Oxidative
coupling, Pd-mediated arylation and the Suzuki cross-coupling reaction were selected as
methods for biaryl bond formation, after which we could elaborate the isoquinoline
skeleton.

xxvii

The focus of Chapter 3 was the formation of the biaryl bond by oxidative coupling.
Ester 145 was selected as the substrate to optimise the oxidation conditions. The
hypervalent iodine reagent PIFA proved the most efficient oxidant, yielding the desired
biaryl product 146 in 85 % under mild reaction conditions. Nucleophilic ring opening of
biaryl lactone 146, hydroxyl protection, Bischler-Napieralski cyclisation and reductive
amination afforded benzylisoquinolines 149 and 152. A series of aromatics, linked by
an ester tether were prepared, and subjected to oxidation with PIFA. In most cases
intramolecular biaryl bond formation failed to occur, largely due to the difference in
electron density of the tethered aromatics. Rather, intermolecular dimerisation occurred.
Dimers possessing hydroquinone character subsequently oxidised to quinones, while
esters possessing a p-methoxy substitution pattern were uniformly cleaved in a DDQ
type fashion.
In Chapter 4 our attention turned to the preparation of biaryl lactones using the Pdmediated arylation of mono-iodinated aromatics, tethered to an electron rich aromatic
by an ester tether. The tether was constructed at specific lengths, such that the biaryl
lactone formed would be either a 6-, 7-, or 8-membered fused ring system following
biaryl bond formation. Heating of our monoiodinated esters with Pd(II) and a base in
DMA in a sealed tube revealed formation of 6-membered rings to be the favoured
outcome, particularly when the halogenated ring also possessed an electron withdrawing
substitutient, thereby increasing the electrophilic nature of the palladium species
following oxidative insertion into the aryl halide bond. Biaryl lactones 242, 243 and 245
were prepared under these conditions, however the lactone stability to aminolysis has
prevented their conversion into phenylisoquinolines. Increasing the tether length by one
methylene carbon revealed the fragility of phenol derived esters as compounds 258,
260, 262 and 263 all decomposed under the reaction conditions, preventing the
xxviii

formation of 7-membered lactones by this methodology. Increasing the tether length by
a second methylene carbon revealed a propensity to form a Pd-enolate, resulting in the
formation of cinnamate 265 and isochromans 268 and 275. The chemistry presented in
Chapters 3 and 4 revealed some interesting results, however the oxidative coupling and
Pd-mediated arylation reactions described did not offer a systematic methodology for
the preparation of various isoquinolines possessing a biaryl moiety.
In Chapter 5 the Suzuki cross coupling reaction was selected as the method of biaryl
bond construction. Electron rich aryl halides 314, 325, and 340 were converted to aryl
boronates with bis(pinacolato)diboron in the presence of a Pd catalyst. Boronates 315,
326 and 337 were cross-coupled with the electron deficient iodide 230 in uniformly
good yields to furnish biaryls 316, 327 and 338, respectively. Deprotection of biaryl 316
afforded lactone the 317, a compound requiring AlMe3 assisted (Weinreb technology)
aminolysis with amine 90. Alcohol protection, Bischler-Napieralski cyclisation and
reductive amination afforded phenylisoquinoline 323. Amide boronate 326 crosscoupled exceptionally well with 230 after which Bischler-Napieralski cyclisation and
reductive amination afforded the phenylethylisoquinoline 309. Deprotection of biaryl
338 revealed a primary alcohol that required a 2-step oxidation, Dess-Martin
periodinane and then NaClO2, to generate the carboxylic acid precursor of the
benzylisoquinoline 308. Amide formation, cyclisation and reductive amination
converted acid 339 into the benzylisoquinoline 308 in respectable yield.
Final compounds and strategic intermediates prepared in Chapters 2-4 were subjected to
biological assay. These compounds were tested against 3-cancer cell lines for
cytotoxicity in addition to assessment for anti-HIV activity, anti-microbial activity and
CNS receptor binding potency. Chapter 6 presents the results of the biological data
collected. Unfortunately, each of the compounds assessed were not active enough to
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warrant further investigation as therapeutic agents, or were totally inactive. We are yet
to submit isoquinolines 308, 309 and 323, prepared in Chapter 5, for biological assay.
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